IPHA

Innate Pharma
IPHA

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$6.5
259% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Swayampakula Ramakanth
75% 1-yr IPHA win rate
29 Oct ‘25 2 months ago
BTIG
BTIG
Justin Zelin
0% 1-yr IPHA win rate
29 Oct ‘25 2 months ago